The forecasted sales of anxiolytic medicine in Norway are expected to remain stable from 2024 to 2028, with a constant value of 2.6 US Dollars PPP per capita. Compared to 2023, there is no year-on-year variation, as the sales values are projected to remain unchanged. This suggests a flat trend in the anxiolytic medicine market for the coming years.

Future trends to watch for:

Potential impact of new anxiolytic medications entering the market and their adoption rates.
Policy changes regarding mental health treatment and medication reimbursement.
Changes in population demographics and mental health prevalence rates.